MCID: INF037
MIFTS: 62

Inflammatory Bowel Disease

Categories: Gastrointestinal diseases, Genetic diseases, Rare diseases, Bone diseases, Blood diseases, Immune diseases

Aliases & Classifications for Inflammatory Bowel Disease

MalaCards integrated aliases for Inflammatory Bowel Disease:

Name: Inflammatory Bowel Disease 12 3 14
Inflammatory Bowel Diseases 52 42 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0050589
MeSH 42 D015212
NCIt 47 C3138
UMLS 69 C0021390

Summaries for Inflammatory Bowel Disease

CDC : 3 Inflammatory Bowel Disease (IBD) is a broad term that describes conditions characterized by chronic inflammation of the gastrointestinal tract. The two most common inflammatory bowel diseases are ulcerative colitis and Crohn’s disease. Inflammation affects the entire digestive tract in Crohn’s disease and only the large intestine (also called the colon) in ulcerative colitis. Both illnesses involved an abnormal response to the body’s immune system.

MalaCards based summary : Inflammatory Bowel Disease, also known as inflammatory bowel diseases, is related to inflammatory bowel disease 3 and ulcerative colitis. An important gene associated with Inflammatory Bowel Disease is NOD2 (Nucleotide Binding Oligomerization Domain Containing 2), and among its related pathways/superpathways are Inflammatory bowel disease (IBD) and Innate Immune System. The drugs Infliximab and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include colon, bone and t cells, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and hematopoietic system

Disease Ontology : 12 An intestinal disease characterized by inflammation located in all parts of digestive tract.

Wikipedia : 72 Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine.... more...

Related Diseases for Inflammatory Bowel Disease

Diseases in the Inflammatory Bowel Disease family:

Inflammatory Bowel Disease 7 Inflammatory Bowel Disease 23
Inflammatory Bowel Disease 10 Inflammatory Bowel Disease 9
Inflammatory Bowel Disease 12 Inflammatory Bowel Disease 18
Inflammatory Bowel Disease 5 Inflammatory Bowel Disease 19
Inflammatory Bowel Disease 3 Inflammatory Bowel Disease 13
Inflammatory Bowel Disease 11 Inflammatory Bowel Disease 14
Inflammatory Bowel Disease 16 Inflammatory Bowel Disease 15
Inflammatory Bowel Disease 20 Inflammatory Bowel Disease 28, Early Onset, Autosomal Recessive
Inflammatory Bowel Disease 2 Inflammatory Bowel Disease 26
Inflammatory Bowel Disease 27 Inflammatory Bowel Disease 4
Inflammatory Bowel Disease 8 Inflammatory Bowel Disease 22
Inflammatory Bowel Disease 21 Inflammatory Bowel Disease 6
Inflammatory Bowel Disease 24 Inflammatory Bowel Disease 25, Early Onset, Autosomal Recessive

Diseases related to Inflammatory Bowel Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 585)
id Related Disease Score Top Affiliating Genes
1 inflammatory bowel disease 3 34.6 IFNG IL18 IL1B NOD2 TNF
2 ulcerative colitis 34.2 IL10 IL6 TNF
3 gastroduodenal crohn's disease 32.2 IL17A IL6 NOD2 TLR2 TLR4 TNF
4 primary biliary cirrhosis 31.0 IL10 IL10RA IL6 TNF
5 hepatitis b 31.0 IFNG IL10 IL18 TNF
6 epidermolysis bullosa acquisita 30.9 IFNG IL10 IL17A STAT3
7 basidiobolomycosis 30.9 IL10 IL4 TNF
8 lymphocytic colitis 30.9 IFNG IL4 IL6 TNF
9 alopecia 30.7 IL10 IL22 IL6 TNF
10 hemophagocytic lymphohistiocytosis 30.7 IFNG IL10 IL6 TNF
11 lymphoma 30.7 IFNG IL10 IL13 IL17A IL1B IL4
12 hypospadias 30.6 IFNG IL10 TLR2 TNF
13 epidermolysis bullosa 30.3 IFNG IL13 IL17A IL4 NOD2 STAT3
14 microscopic colitis 29.8 ABCB1 ATG16L1 IFNG IL10 IL10RA IL17A
15 atherosclerosis 29.8 IFNG IL10 IL17A IL18 IL1B IL6
16 systemic lupus erythematosus 29.8 IFNG IL10 IL17A IL18 IL4 IL6
17 rheumatoid arthritis 29.4 IFNG IL10 IL17A IL18 IL1B IL23A
18 asthma 29.2 IFNG IL10 IL13 IL17A IL18 IL1B
19 inflammatory bowel disease 25, early onset, autosomal recessive 12.4
20 inflammatory bowel disease 2 12.3
21 inflammatory bowel disease 4 12.3
22 inflammatory bowel disease 5 12.3
23 inflammatory bowel disease 28, early onset, autosomal recessive 12.3
24 inflammatory bowel disease 19 12.3
25 inflammatory bowel disease 20 12.3
26 inflammatory bowel disease 10 12.3
27 inflammatory bowel disease 13 12.3
28 inflammatory bowel disease 14 12.3
29 inflammatory bowel disease 17, protection against 12.3
30 inflammatory bowel disease 9 12.2
31 inflammatory bowel disease 8 12.2
32 inflammatory bowel disease 16 12.2
33 inflammatory bowel disease 6 12.2
34 inflammatory bowel disease 7 12.2
35 inflammatory bowel disease 23 12.2
36 inflammatory bowel disease 26 12.2
37 inflammatory bowel disease 27 12.2
38 inflammatory bowel disease 11 12.2
39 inflammatory bowel disease 12 12.2
40 inflammatory bowel disease 22 12.2
41 inflammatory bowel disease 21 12.2
42 inflammatory bowel disease 15 12.2
43 inflammatory bowel disease 18 12.2
44 inflammatory bowel disease 24 12.2
45 crohn disease-associated growth failure 11.8
46 gastrointestinal defects and immunodeficiency syndrome 11.5
47 crohn's disease 11.4
48 irritable bowel syndrome 11.3
49 colitis 11.3
50 collagenous colitis 11.2

Graphical network of the top 20 diseases related to Inflammatory Bowel Disease:



Diseases related to Inflammatory Bowel Disease

Symptoms & Phenotypes for Inflammatory Bowel Disease

GenomeRNAi Phenotypes related to Inflammatory Bowel Disease according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.77 IL17A IL18 IL1B NOD1 NOD2 TNF
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.77 IL18 IL1B NOD1 NOD2 TNF IL10

MGI Mouse Phenotypes related to Inflammatory Bowel Disease:

44 (show all 19)
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.51 ABCB1 ATG16L1 IFNG IL10 IL10RA IL13
2 digestive/alimentary MP:0005381 10.5 ABCB1 ATG16L1 IFNG IL10 IL10RA IL13
3 immune system MP:0005387 10.49 IL23R IL4 IL6 NOD1 NOD2 STAT3
4 homeostasis/metabolism MP:0005376 10.48 ATG16L1 IFNG IL10 IL10RA IL13 IL17A
5 growth/size/body region MP:0005378 10.42 IL10 IL13 TLR4 IL17A TNF IL18
6 cellular MP:0005384 10.39 ATG16L1 IFNG IL10 IL10RA IL13 IL18
7 mortality/aging MP:0010768 10.36 ABCB1 ATG16L1 IFNG IL10 IL13 IL17A
8 endocrine/exocrine gland MP:0005379 10.34 ABCB1 ATG16L1 IFNG IL10 IL13 IL17A
9 cardiovascular system MP:0005385 10.32 ABCB1 ATG16L1 IFNG IL10 IL18 IL1B
10 integument MP:0010771 10.24 IFNG IL10 IL13 IL18 IL1B IL4
11 nervous system MP:0003631 10.15 ABCB1 ATG16L1 IFNG IL10 IL18 IL1B
12 liver/biliary system MP:0005370 10.13 ABCB1 IFNG IL10 IL4 IL6 STAT3
13 muscle MP:0005369 10.13 ATG16L1 IFNG IL10 IL13 IL18 IL6
14 neoplasm MP:0002006 10.1 IL10 IL1B IL23A IL23R IL6 STAT3
15 no phenotypic analysis MP:0003012 9.97 IL23A IL23R IL4 TNF ABCB1 IFNG
16 reproductive system MP:0005389 9.91 ABCB1 IFNG IL10 IL13 IL4 IL6
17 respiratory system MP:0005388 9.85 IL10 IL13 IL17A IL4 IL6 STAT3
18 skeleton MP:0005390 9.73 IFNG IL10 IL13 IL17A IL1B IL4
19 vision/eye MP:0005391 9.28 ATG16L1 IFNG IL10 IL18 IL4 IL6

Drugs & Therapeutics for Inflammatory Bowel Disease

Drugs for Inflammatory Bowel Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 508)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Infliximab Approved Phase 4,Phase 2,Phase 3,Phase 1 170277-31-3
2
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
3
Clarithromycin Approved Phase 4,Phase 3 81103-11-9 84029
4
Clofazimine Approved, Investigational Phase 4,Phase 3 2030-63-9 2794
5
Rifabutin Approved Phase 4,Phase 3 72559-06-9 6323490
6
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 83-43-2 6741
7
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 50-24-8 5755
8
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
9
Hydrocortisone Approved, Vet_approved Phase 4,Phase 1,Phase 2 50-23-7 5754 657311
10
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3 53-03-2 5865
11
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1 428863-50-7
12
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
13
Rosiglitazone Approved, Investigational Phase 4,Phase 1,Phase 2 122320-73-4 77999
14
Azathioprine Approved Phase 4,Phase 2,Phase 3,Phase 1 446-86-6 2265
15
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
16
Budesonide Approved Phase 4,Phase 3,Phase 2 51333-22-3 63006 5281004
17
Methotrexate Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 1959-05-2, 59-05-2 126941
18
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
19
Aminosalicylic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1 65-49-6 4649
20
Bupropion Approved Phase 4,Phase 2,Phase 3 34841-39-9, 34911-55-2 444
21
Dopamine Approved Phase 4,Phase 2,Phase 3 51-61-6, 62-31-7 681
22
Menthol Approved Phase 4,Phase 1,Phase 2 2216-51-5 16666
23
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
24
Midazolam Approved, Illicit Phase 4,Phase 1 59467-70-8 4192
25
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
26
Lubiprostone Approved, Investigational Phase 4 136790-76-6 656719
27
Etidronic acid Approved Phase 4 7414-83-7, 2809-21-4 3305
28
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
29
Ibuprofen Approved Phase 4 15687-27-1 3672
30
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 73590-58-6 4594
31
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
32
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
33
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 443-48-1 4173
34
Natalizumab Approved, Investigational Phase 4,Phase 3,Phase 2 189261-10-7
35
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 22916-47-8 4189
36
Thioguanine Approved Phase 4,Phase 1 154-42-7 2723601
37
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
38
Vancomycin Approved Phase 4,Phase 3,Phase 2,Phase 1 1404-90-6 441141 14969
39 Vedolizumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 943609-66-3
40
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 1 93-14-1 3516
41
Nicotine Approved Phase 4,Phase 3 54-11-5 942 89594
42
Copper Approved Phase 4 7440-50-8 27099
43
Zinc Approved Phase 4 7440-66-6 32051 23994
44
Everolimus Approved Phase 4,Phase 1,Phase 2 159351-69-6 6442177
45
Sirolimus Approved, Investigational Phase 4,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
46
Ondansetron Approved Phase 4,Phase 3 99614-02-5 4595
47
Dextromethorphan Approved Phase 4 125-71-3 5360696 5362449
48
Losartan Approved Phase 4 114798-26-4 3961
49
Sulfamethazine Approved, Vet_approved Phase 4 57-68-1 5327
50
Dalteparin Approved Phase 4 9005-49-6

Interventional clinical trials:

(show top 50) (show all 1796)

id Name Status NCT ID Phase Drugs
1 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Unknown status NCT01765998 Phase 4 Probiotic;Placebo
2 Confocal Endomicroscopy During Endoscopy Unknown status NCT00988273 Phase 4
3 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator
4 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
5 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
6 The Effect of Vitamin D3 to Maintain Surgical Remission in Postoperative Crohn's Disease Unknown status NCT02010762 Phase 4 Vitamin D;Placebo
7 Evaluation of PET CT in the Management of Patients With Crohn's Disease. Unknown status NCT00731809 Phase 4
8 Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Unknown status NCT00513552 Phase 4 Rifabutin, Clarithromycin, and Clofazimine
9 Participation and Detection Rate Diagnostic of a Colorectal Cancer Screening Program: CT Colonography vs. Flexible Sigmoidoscopy Unknown status NCT01739608 Phase 4
10 Manipulation of Visceral Sensitivity and Immune System in IBS Unknown status NCT00418340 Phase 4 probiotic (bacterial/dietary supplement)
11 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Unknown status NCT01632462 Phase 4 VSL#3
12 Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis Unknown status NCT00265772 Phase 4 MODULEN IBD (R) (specific Enteral Nutrition);prednisolon
13 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Unknown status NCT00851565 Phase 4
14 Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult Unknown status NCT02056418 Phase 4 corticosteroid
15 Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease Unknown status NCT00609752 Phase 4 prednisolone
16 VSL#3 Treatment in Children With Crohn's Disease Unknown status NCT00367705 Phase 4
17 Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission Unknown status NCT01817426 Phase 4 Infliximab
18 Optimizing Cimzia in Crohn's Patients Unknown status NCT01024647 Phase 4
19 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Unknown status NCT02412085 Phase 4 Golimumab
20 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Unknown status NCT02186886 Phase 4 Golimumab
21 Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease Completed NCT01981889 Phase 4 Prednisone
22 Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease Completed NCT01908283 Phase 4
23 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
24 Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Completed NCT02162862 Phase 4 bupropion-SR
25 Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) Completed NCT02437591 Phase 4 fidaxomicin
26 Low Volume Colon Preparation for IBD Completed NCT02248337 Phase 4 Colon preparation for colonoscopy
27 Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate Completed NCT01991314 Phase 4 Ferrous sulphate
28 Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients Completed NCT01341808 Phase 4
29 Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) Completed NCT01346826 Phase 4 Standard 2 hours-infusion;Accelerated 1 hour-infusion;Accelerated 30 minutes-infusion
30 A Trial of Iron Replacement in Patients With Iron Deficiency. Completed NCT01067547 Phase 4 Iron Sucrose.;Iron sucrose
31 Gene Regulation by Thiazolidinediones Completed NCT00567593 Phase 4 Rosiglitazone
32 Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy Completed NCT01934088 Phase 4 Propofol;Midazolam;Fentanyl
33 Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy Completed NCT00746395 Phase 4 Lubiprostone;Placebo
34 The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels Completed NCT00167882 Phase 4 5-aminosalicylate (Pentasa, Ferring)
35 Post Marketing Surveillance of Remicade Completed NCT00724529 Phase 4
36 Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease Completed NCT02148718 Phase 4
37 Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle Completed NCT01772615 Phase 4 Ciprofloxacin
38 Dose Escalation and Remission (DEAR) Completed NCT00652145 Phase 4 mesalamine
39 Pneumococcal Vaccination of Crohn Patients Completed NCT01947010 Phase 4
40 Efficacy Study of Pneumococcal Vaccination in Crohn's Disease Completed NCT01505855 Phase 4 23-valent polysaccharide pneumococcal vaccine
41 Vitamin D in Pediatric Crohn's Disease Completed NCT01187459 Phase 4
42 Intragastric and Peritoneal Microdialysis in Infants With Necrotizing Enterocolitis (NEC) Completed NCT00332592 Phase 4
43 Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease Completed NCT01215890 Phase 4 risedronate;placebo
44 Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole Completed NCT00640809 Phase 4 Celecoxib;Ibuprofen plus Omeprazole
45 Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis Completed NCT01418131 Phase 4 Rectal tacrolimus;Placebo
46 NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery Completed NCT01056913 Phase 4
47 The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) Completed NCT01668004 Phase 4
48 Prevalence of Colon Cancer in Pyogenic Liver Abscess Completed NCT02032914 Phase 4
49 Asacol Dosing Study for Active Ulcerative Colitis Completed NCT00194818 Phase 4 Asacol (mesalamine)
50 Endoscopic Detection of Dysplasia in Crohn 's Disease Patient Completed NCT01180452 Phase 4

Search NIH Clinical Center for Inflammatory Bowel Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: inflammatory bowel diseases

Genetic Tests for Inflammatory Bowel Disease

Anatomical Context for Inflammatory Bowel Disease

MalaCards organs/tissues related to Inflammatory Bowel Disease:

39
Colon, Bone, T Cells, Testes, Small Intestine, Liver, Endothelial

Publications for Inflammatory Bowel Disease

Articles related to Inflammatory Bowel Disease:

(show top 50) (show all 2704)
id Title Authors Year
1
Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis. ( 28523573 )
2017
2
Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study. ( 28953003 )
2017
3
Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199]. ( 28042931 )
2017
4
Risk of inflammatory bowel disease in patients with rosacea: Results from a nationwide cohort study in Taiwan. ( 28073582 )
2017
5
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. ( 27693347 )
2017
6
De novo and rare mutations in the HSPA1L heat shock gene associated with inflammatory bowel disease. ( 28126021 )
2017
7
Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis? ( 28776143 )
2017
8
Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population. ( 28456797 )
2017
9
Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa. ( 28089682 )
2017
10
Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease. ( 28337881 )
2017
11
Hypoxia inducible factor-1I+-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease. ( 27921309 )
2017
12
The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease. ( 28932959 )
2017
13
Glutathione S-Transferase T1 Null Genotype is Associated with Susceptibility to Inflammatory Bowel Disease. ( 28472806 )
2017
14
Resveratrol and inflammatory bowel disease. ( 28945937 )
2017
15
Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners. ( 28092305 )
2017
16
MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease. ( 28153728 )
2017
17
Screening for Epstein-Barr Virus Status and Risk of Hemophagocytic Lymphohistiocytosis in Children With Inflammatory Bowel Disease on Azathioprine. ( 28881189 )
2017
18
Gut biofilm forming bacteria in inflammatory bowel disease. ( 28942174 )
2017
19
Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. ( 28949021 )
2017
20
Correction to: Carvalho et al., Prevalence of iron deficiency anemia and iron deficiency in a pediatric population with inflammatory bowel disease. ( 28853335 )
2017
21
Successful treatment of Common Variable Immunodeficiency-associated inflammatory bowel disease with Ustekinumab. ( 28333242 )
2017
22
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. ( 28368383 )
2017
23
Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model? ( 28560286 )
2017
24
Critical role of Keratin 1 in maintaining epithelial barrier and correlation of its down-regulation with the progression of inflammatory bowel disease. ( 28111259 )
2017
25
Pharmacotranscriptomic biomarkers in glucocorticoid treatment of pediatric inflammatory bowel disease. ( 28933291 )
2017
26
Anti-TNFI+ Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease. ( 28953529 )
2017
27
Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease. ( 28932092 )
2017
28
Parental Distress and Quality of Life in Pediatric Inflammatory Bowel Disease: Implications for the Outpatient Clinic. ( 28953528 )
2017
29
Acquired von Willebrand syndrome in inflammatory bowel disease. ( 28314057 )
2017
30
Elevated levels of IL-2 and IL-21 produced by CD4+ T cells in inflammatory bowel disease. ( 28685527 )
2017
31
Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study. ( 28945636 )
2017
32
I+2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease. ( 28210079 )
2017
33
Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria. ( 28597107 )
2017
34
Herpes Simplex Proctitis Mimicking Inflammatory Bowel Disease in a Teenaged Male. ( 28473937 )
2017
35
Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. ( 28947877 )
2017
36
Pilot study: duodenal MDR1 and COX2 gene expression in cats with inflammatory bowel disease and low-grade alimentary lymphoma. ( 28948903 )
2017
37
The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD). ( 27909059 )
2017
38
Ankyrin repeat and zinc-finger domain-containing 1 mutations are associated with infantile-onset inflammatory bowel disease. ( 28302725 )
2017
39
IMPORTANCE OF MEASURING LEVELS OF INFLIXIMAB IN PATIENTS TREATING INFLAMMATORY BOWEL DISEASE IN A BRAZILIAN COHORT. ( 28954041 )
2017
40
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers. ( 28922435 )
2017
41
Bactericidal/permeability increasing protein gene polymorphism and inflammatory bowel diseases: meta-analysis of five case-control studies. ( 28035462 )
2017
42
Pre-illness diet as risk factor in pediatric inflammatory bowel disease in Saudi Arabia. ( 28937023 )
2017
43
The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. ( 28934123 )
2017
44
Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea. ( 28930861 )
2017
45
Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011. ( 28796371 )
2017
46
Reduced NHE3 activity results in congenital diarrhea and can predispose to inflammatory bowel disease. ( 28250009 )
2017
47
Insight into the role of TSLP in inflammatory bowel diseases. ( 27697608 )
2017
48
Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic. ( 28932369 )
2017
49
Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission. ( 28138990 )
2017
50
Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis. ( 28412702 )
2017

Variations for Inflammatory Bowel Disease

Expression for Inflammatory Bowel Disease

Search GEO for disease gene expression data for Inflammatory Bowel Disease.

Pathways for Inflammatory Bowel Disease

Pathways related to Inflammatory Bowel Disease according to KEGG:

37
id Name Kegg Source Accession
1 Inflammatory bowel disease (IBD) hsa05321